Efficacy and safety of CagriSema & Retatrutide, CGM benefits beyond T2D, & more!
About this episode
This episode reviews the latest research on diabetes treatments and monitoring technologies.
Welcome to the latest episode (July 2026) of DOC Updates , where every month Neil Skolnik, MD and John Russell, MD review the most important articles on diabetes, obesity, and cardiometabolic disease. This month on DOC Updates : Aroda V, Buzzetti R, Dalskov S et al. " Efficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study ." The Lancet Diabetes & Endocrinology, 2026; 0 doi: 10.1016/S2213-8587(26)00126-9 Bajaj H, Welch M, Shah P et al. " Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial ." The Lancet, 2026; 407, 2402-2413 doi: 10.1016/S0140-6736(26)00967-0 Melville, N. " CGM Monitoring Benefits Extend to Non-Insulin-Using T2D ." Medscape, June 07, 2026 Aronne, L.J., Horn, D.B., le Roux, C.W. et al. " Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial ." Nat Med(2026) doi…
More episodes of Diabetes Core Update
- Special Edition: What's Next—Once-Weekly Insulins—Mechanisms and Practical Considerations
- Special Edition: What's Next—CKD in Type 1 Diabetes—An Urgent Need for Therapies
- Special Edition: Medications in the Pipeline for Cardiometabolic Disease
- Special Edition: The Diabetes, Obesity, and CardioMetabolic CARE Symposium—The Cost of Obesity and Its Treatment
- Anna Kahkoska & Joshua Niznik on Patient Portal Messages and Older Adults with T2D, Esben Thyssen Vestergaard on Clinic for Athletes with T1D, and more!
- Food coloring additives & T2D, automated insulin delivery systems in T2D, and more!
Explore listener stats, chart rankings, contacts and more on the Diabetes Core Update podcast page.